- Home
- CRGX vs FIGS Comparison
CRGX vs FIGS Comparison
Compare CRGX & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- FIGS
- Stock Information
- Founded
- CRGX 2021
- FIGS 2013
- Country
- CRGX United States
- FIGS United States
- Employees
- CRGX N/A
- FIGS N/A
- Industry
- CRGX
- FIGS Apparel
- Sector
- CRGX
- FIGS Consumer Discretionary
- Exchange
- CRGX Nasdaq
- FIGS Nasdaq
- Market Cap
- CRGX 964.5M
- FIGS 1.1B
- IPO Year
- CRGX 2023
- FIGS 2021
- Fundamental
- Price
- CRGX $16.00
- FIGS $4.93
- Analyst Decision
- CRGX Strong Buy
- FIGS Hold
- Analyst Count
- CRGX 7
- FIGS 6
- Target Price
- CRGX $30.33
- FIGS $5.40
- AVG Volume (30 Days)
- CRGX 167.8K
- FIGS 3.1M
- Earning Date
- CRGX 11-12-2024
- FIGS 11-07-2024
- Dividend Yield
- CRGX N/A
- FIGS N/A
- EPS Growth
- CRGX N/A
- FIGS N/A
- EPS
- CRGX N/A
- FIGS 0.05
- Revenue
- CRGX N/A
- FIGS $548,644,000.00
- Revenue This Year
- CRGX N/A
- FIGS $2.82
- Revenue Next Year
- CRGX N/A
- FIGS $3.86
- P/E Ratio
- CRGX N/A
- FIGS $89.51
- Revenue Growth
- CRGX N/A
- FIGS 0.55
- 52 Week Low
- CRGX $13.56
- FIGS $4.30
- 52 Week High
- CRGX $33.92
- FIGS $7.98
- Technical
- Relative Strength Index (RSI)
- CRGX 32.69
- FIGS 33.50
- Support Level
- CRGX $19.96
- FIGS $4.65
- Resistance Level
- CRGX $23.00
- FIGS $5.14
- Average True Range (ATR)
- CRGX 1.79
- FIGS 0.29
- MACD
- CRGX -0.58
- FIGS -0.15
- Stochastic Oscillator
- CRGX 7.04
- FIGS 21.96
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company markets and sells its products in the United States. Sales are generated through the Company's digital platforms.